147 related articles for article (PubMed ID: 6105670)
21. [Tardive dyskinesia--research results and preventive measures].
Gunne LM
Lakartidningen; 1987 Apr; 84(17):1458-63. PubMed ID: 3586787
[No Abstract] [Full Text] [Related]
22. Dopaminergic and GABAergic aspects of tardive dyskinesia [proceedings].
Casey DE; Gerlach J; Magelund G; Christensen TR
Psychopharmacol Bull; 1981 Jan; 17(1):49-50. PubMed ID: 7232658
[No Abstract] [Full Text] [Related]
23. Antagonism of dopamine supersensitivity by estrogen: neurochemical studies in an animal model of tardive dyskinesia.
Gordon JH; Diamond BI
Biol Psychiatry; 1981 Apr; 16(4):365-71. PubMed ID: 7194695
[TBL] [Abstract][Full Text] [Related]
24. [Tardive dyskinesia].
Kato M; Watanabe K
Ryoikibetsu Shokogun Shirizu; 2003; (38):183-7. PubMed ID: 12876961
[No Abstract] [Full Text] [Related]
25. Is there a presynaptic tardive dyskinesia?
Bowers MB; Glazer WM
J Clin Psychopharmacol; 1987 Feb; 7(1):57-9. PubMed ID: 2880877
[No Abstract] [Full Text] [Related]
26. Similar effect of estradiol and haloperidol on experimental tardive dyskinesia in monkeys.
Bédard PJ; Boucher R; Daigle M; Di Paolo T
Psychoneuroendocrinology; 1984; 9(4):375-9. PubMed ID: 6514933
[TBL] [Abstract][Full Text] [Related]
27. Treatment of tardive dyskinesia.
Hollister LE
Curr Psychiatr Ther; 1980; 19():89-97. PubMed ID: 6109597
[No Abstract] [Full Text] [Related]
28. Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain.
Bishnoi M; Chopra K; Kulkarni SK
Pharmacol Biochem Behav; 2008 Feb; 88(4):511-22. PubMed ID: 18022680
[TBL] [Abstract][Full Text] [Related]
29. Sustained gamma-aminobutyric acid receptor stimulation and chronic neuroleptic effects.
Lloyd KG; Worms P
Adv Biochem Psychopharmacol; 1980; 24():253-8. PubMed ID: 6105780
[No Abstract] [Full Text] [Related]
30. In vivo microdialysis studies of striatal level of neurotransmitters after haloperidol and chlorpromazine administration.
Kulkarni SK; Bishnoi M; Chopra K
Indian J Exp Biol; 2009 Feb; 47(2):91-7. PubMed ID: 19374163
[TBL] [Abstract][Full Text] [Related]
31. Neurochemical changes associated with chronic administration of typical antipsychotics and its relationship with tardive dyskinesia.
Bishnoi M; Chopra K; Kulkarni SK
Methods Find Exp Clin Pharmacol; 2007 Apr; 29(3):211-6. PubMed ID: 17520104
[TBL] [Abstract][Full Text] [Related]
32. Modulation of tardive dyskinesia by estrogen: neurochemical studies in an animal model.
Gordon JH; Diamond BI
Trans Am Neurol Assoc; 1979; 104():97-100. PubMed ID: 553438
[No Abstract] [Full Text] [Related]
33. Epidemiology and pathophysiology of tardive dyskinesias.
Klawans HL; Tanner CM; Goetz CG
Adv Neurol; 1988; 49():185-97. PubMed ID: 2894124
[No Abstract] [Full Text] [Related]
34. Anticholinergics promote neuroleptic-induced tardive dyskinesia.
Borison RL; Diamond BI
Adv Biochem Psychopharmacol; 1980; 24():359-61. PubMed ID: 6105786
[No Abstract] [Full Text] [Related]
35. [Current theories on the role of dopamine in the mechanism of action of neuroleptic drugs].
Płaźnik A; Kostowski W
Psychiatr Pol; 1984; 18(1):39-47. PubMed ID: 6146150
[No Abstract] [Full Text] [Related]
36. [Late dyskinesia: experimental models, paradoxes and deductions].
Vamvakidès A
Agressologie; 1987 Sep; 28(8):827-30. PubMed ID: 2827536
[No Abstract] [Full Text] [Related]
37. Altered receptor sensitivity following chronic drug administration in man: the tardive dyskinesia model [proceedings].
Rubovits R
Psychopharmacol Bull; 1977 Jan; 13(1):49-50. PubMed ID: 402011
[No Abstract] [Full Text] [Related]
38. Chronic neuroleptic treatment and dopamine receptor regulation.
Creese I; Snyder SH
Adv Biochem Psychopharmacol; 1980; 24():89-94. PubMed ID: 6105809
[No Abstract] [Full Text] [Related]
39. The relationship between dopamine D2 receptor occupancy and the vacuous chewing movement syndrome in rats.
Turrone P; Remington G; Kapur S; Nobrega JN
Psychopharmacology (Berl); 2003 Jan; 165(2):166-71. PubMed ID: 12417967
[TBL] [Abstract][Full Text] [Related]
40. Dogma disputed: is tardive dyskinesia due to postsynaptic dopamine receptor supersensitivity?
Jeste DV; Wyatt RJ
J Clin Psychiatry; 1981 Dec; 42(12):455-7. PubMed ID: 6118358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
